Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT01370278
Official study title

Clearance Of Mucus In Stents (COMIS)

Study summary

The goal of this clinical research study is to compare the effects of sodium bicarbonate to normal saline when used for clearing mucus blockage in patients with airway stents.

Ask AI to explain this study
Start here

Key things to know

Main goalDiagnostic

This describes the study’s primary purpose.

What is being studiedNormal Saline and Sodium Bicarbonate

The study team can explain what participation involves.

Who it may be forLung Neoplasms · Respiratory Failure

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 25, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?M.D. Anderson Cancer Center

Study sponsor

01
Study overview

What this study is about

Purpose
Diagnostic
Study type
Interventional
Phase
Not applicable
Sponsor
M.D. Anderson Cancer Center
Interventions being studied
Other: Normal Saline; Other: Sodium Bicarbonate
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Adult patients (\>/= 18 years) with airway stents undergoing bronchoscopy. 2. Patients previously enrolled, but excluded as no stent lumen obstruction from mucus retention identified at earlier enrollment (hence excluded at that enrollment) .

Reasons someone may not be able to joinExclusion criteria

1. Patients with history of allergy or adverse reactions to sodium bicarbonate or normal saline. 2. Patients refusing to sign informed written consent for participation in research. 3. Patients with no stent lumen occlusion from mucus impaction as determined at the time of the initial visual bronchoscopic assessment. 4. Previously enrolled patients who completed this protocol.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Texas MD Anderson Cancer CenterHouston, Texas

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 25, 2023. Always confirm current availability with the study team.

View original record ↗